Effects of an acebutolol-hydrochlorothiazide combination on urinary solute excretion in healthy adults.
Ten healthy adult male volunteers were studied to assess the urinary effects of a single dose of a combination of hydrochlorothiazide 12.5 mg and acebutolol 200 mg (HZAL). The formation induced a significant increase in the 24-hour urinary output of sodium. Outputs of fluid, chloride, potassium, calcium, magnesium, zinc, total inorganic phosphate and creatinine were unaffected. With the exception of Mg2+ flow, times to maximal urinary flows of fluid and solutes were shortened by HZAL. These qualitative changes resemble those induced by hydrochlorothiazide but did not achieve quantitative significance, either because the constituent diuretic dose was too small or because acebutolol compensated for some of its effects.
D000070:Acebutolol / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D002118:Calcium / Q000652:urine; D002712:Chlorides / Q000652:urine; D003404:Creatinine / Q000652:urine; D004347:Drug Interactions; D004573:Electrolytes / Q000652:urine*; D006801:Humans; D006852:Hydrochlorothiazide / Q000494:pharmacology*; D008274:Magnesium / Q000652:urine; D008297:Male; D010710:Phosphates / Q000652:urine; D011188:Potassium / Q000652:urine; D012964:Sodium / Q000652:urine; D013997:Time Factors; D015032:Zinc / Q000652:urine
D002712:Chlorides; D004573:Electrolytes; D010710:Phosphates; D006852:Hydrochlorothiazide; D000070:Acebutolol; D012964:Sodium; D003404:Creatinine; D008274:Magnesium; D015032:Zinc; D011188:Potassium; D002118:Calcium